LEVIPREP

Serial Number 98366148
Registration 7631160
700

Registration Progress

Application Filed
Jan 19, 2024
Under Examination
Approved for Publication
Sep 24, 2024
Published for Opposition
Sep 24, 2024
Registered
Dec 31, 2024

Trademark Image

LEVIPREP

Basic Information

Serial Number
98366148
Registration Number
7631160
Filing Date
January 19, 2024
Registration Date
December 31, 2024
Published for Opposition
September 24, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 31, 2024
Registration
Registered
Classes
001 005

Rights Holder

LEVITASBIO, INC.

03
Address
1455 ADAMS DRIVE
MENLO PARK, CA 94025

Ownership History

LEVITASBIO, INC.

Original Applicant
03
MENLO PARK, CA

LEVITASBIO, INC.

Owner at Publication
03
MENLO PARK, CA

LEVITASBIO, INC.

Original Registrant
03
MENLO PARK, CA

Legal Representation

Attorney
Jason Sanders

USPTO Deadlines

Next Deadline
1980 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-31)
Due Date
December 31, 2030
Grace Period Ends
June 30, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

11 events
Date Code Type Description Documents
Dec 31, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 31, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 4, 2024 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Oct 23, 2024 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Sep 24, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 24, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 4, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 20, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 14, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 19, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 19, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Reagents, cartridges and testing kits comprised of diagnostic reagents and assays for testing cell gene expression and cell data for scientific and research purposes; testing kits, namely, chemical preparations, compounds, enzymes, and fluids sold together as a unit for scientific and research purposes
First Use Anywhere: Mar 15, 2022
First Use in Commerce: Mar 15, 2022
Class 005
Reagents, cartridges and testing kits comprised of medical diagnostic reagents and assays for testing cell gene expression and cell data for medical diagnostic use; testing kits, namely, chemical preparations, compounds, enzymes, and fluids sold together as a unit for medical diagnostic purposes
First Use Anywhere: Mar 15, 2022
First Use in Commerce: Mar 15, 2022

Classification

International Classes
001 005